Clinical Trials Logo

Clinical Trial Summary

Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.


Clinical Trial Description

This is a single centre, parallel-group, double-blind, randomized, placebo-controlled pilot clinical trial for adults suffering from complex regional pain syndrome (CRPS).

Twelve (12) subjects diagnosed with CRPS will be enrolled and randomized to receive orally, either ethosuximide or placebo. If the maximum trial medication dosage (1500mg) is reached, the subject will be in the study for a maximum of 10 weeks from screening (Clinic Visit 1) to the end of the drug cessation period. The minimum period a subject could complete the study would be 4 weeks presuming they were not previously on any disallowed drugs and only found the 500mg dose tolerable. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00689585
Study type Interventional
Source McGill University Health Center
Contact
Status Terminated
Phase Phase 2
Start date September 2008
Completion date July 2010

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04066933 - Forms of Cervical Brachial Syndrome Treated With Plasma Concentrate Enriched for A2M
Completed NCT04597866 - Treatment of Complex Regional Pain Syndrome, a Long-term Follow-up
Completed NCT04060875 - Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
Not yet recruiting NCT06453447 - Prednisone for CRPS in Distal Radius Fracture N/A
Terminated NCT01954888 - Impact of the Ultrasound-guided Approach on the Efficiency and Safety of the Stellate Ganglion Block in Chronic Pain N/A
Recruiting NCT00377468 - Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) Phase 2
Recruiting NCT05787119 - Benefit of Augmented Reality Mirror Therapy in Addition to Conventional Management in Complex Regional Pain Syndrome of the Upper Extremity N/A
Recruiting NCT05523934 - Retrospective Analysis of capsaïcin Patch in Complex Regional Pain Syndrome
Recruiting NCT04732325 - Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain N/A
Completed NCT03174249 - Exposure Therapy Combined With Cortical Interventions for CRPS-II N/A
Recruiting NCT06033456 - Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome N/A
Recruiting NCT04144972 - Closed-Loop Deep Brain Stimulation for Refractory Chronic Pain N/A
Completed NCT02490436 - Novel Treatment Option for Neuropathic Pain Phase 2
Withdrawn NCT03316066 - Comparison of Volumes of Local Anesthetics on the Efficiency and Safety of Stellate Ganglion Block for CRPS of the Arm N/A
Recruiting NCT05491499 - Assessing the Impact of Exercise Based Intensive Interdisciplinary Pain Treatment (IIPT) on Endogenous Pain Modulation in Youth With Chronic Pain Syndromes
Completed NCT03291197 - Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome Phase 4
Recruiting NCT05034835 - Impact of Compression Garments on Pain in Patients With Complex Regional Pain Syndrome of the Upper Limbs. N/A
Completed NCT05696587 - Physical and Psychological Changes in CRPS Patients Undergoing Multimodal Rehabilitation N/A
Recruiting NCT02957240 - Graded Motor Imagery for Women at Risk for Developing Type I CRPS Following Closed Treatment of Distal Radius Fractures N/A
Terminated NCT00891397 - Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study) N/A